Serum samples from pancreatectomized patients contain trypsinogen immunoreactivity.

[1]  B. Müller-Hill,et al.  Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. , 1993, Gene.

[2]  T. Terada,et al.  Extrahepatic peribiliary glands express α‐amylase isozymes, trypsin and pancreatic lipase: An immunohistochemical analysis , 1993, Hepatology.

[3]  O. Itkonen,et al.  Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor‐associated trypsinogen , 1991, International journal of cancer.

[4]  O. Itkonen,et al.  Biology and function of tumor-associated trypsin inhibitor, TATI. , 1991, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[5]  O. Itkonen,et al.  Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. , 1990, The Journal of laboratory and clinical medicine.

[6]  O. Itkonen,et al.  Cyst fluid of ovarian cancer patients contains high concentrations of trypsinogen-2. , 1990, Cancer research.

[7]  U. Stenman,et al.  Characterization of a tumor-associated serine protease. , 1987, Biological chemistry Hoppe-Seyler.

[8]  K. Ohlsson,et al.  Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells. , 1986, Journal of clinical pathology.

[9]  M. Kenichi,et al.  Cloning, characterization and nucleotide sequences of two cDNAs encoding human pancreatic trypsinogens. , 1986 .

[10]  U. Stenman,et al.  Pancreatic secretory trypsin inhibitor-like immunoreactivity in pancreatectomized patients. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[11]  R. Jorde,et al.  Radioimmunoassay of cationic trypsin-like immunoreactivity in man. , 1984, Scandinavian journal of gastroenterology.

[12]  S. Abramson,et al.  Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid. , 1984, Gastroenterology.

[13]  I. Cobden,et al.  初期食道静脈りゅう治療におけるテルイプレシン(グリプレシン)とバソプレシンの比較試験 , 1982 .

[14]  G. Scheele,et al.  Characterization of Human Exocrine Pancreatic Proteins by Two-Dimensional Isoelectric Focusing/Sodium Dodecyl Sulfate Gel Electrophoresis , 1981 .

[15]  A. Barrett,et al.  Proteinases and tumor invasion , 1980 .

[16]  J. H. Johnson,et al.  Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera. , 1979, The American journal of physiology.

[17]  JeanetteR. Crossle,et al.  DRIED-BLOOD SPOT SCREENING FOR CYSTIC FIBROSIS IN THE NEWBORN , 1979, The Lancet.

[18]  J. H. Johnson,et al.  Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay. , 1979, The American journal of physiology.

[19]  J. H. Johnson,et al.  Demonstration of human pancreatic anionic trypsinogen in normal serum by radioimmunoassay. , 1978, Biochimica et biophysica acta.

[20]  G. Moore,et al.  Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. , 1978, Cancer research.

[21]  E. Elias,et al.  DIAGNOSTIC IMPORTANCE OF CHANGES IN CIRCULATING CONCENTRATIONS OF IMMUNOREACTIVE TRYPSIN , 1977, The Lancet.

[22]  K. Ohlsson,et al.  Radioimmunological determination and characterization of cathodal trypsin-like immunoreactivity in normal human plasma. , 1976, Scandinavian journal of clinical and laboratory investigation.

[23]  J. Travis,et al.  Human pancreatic enzymes. Characterization of anionic huyman trypsin. , 1973, Biochemistry.